
Sciensus Pharma Services Limited - Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI’s, and Recent Trends
Description
Report Summary
Sciensus Pharma Services Limited - Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI’s, and Recent Trends is a comprehensive and easily accessible overview of Sciensus Pharma Services Limited 's business operations. It provides a detailed analysis of the company's strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Sciensus Pharma Services Limited including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Sciensus Pharma Services Limited's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. By integrating these strategic analyses, the report offers a comprehensive understanding of Sciensus Pharma Services Limited's overall strategic standing and supports informed decision-making and strategic planning.
Finally, the report includes recent news and deal activities undertaken by Sciensus Pharma Services Limited enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Sciensus Pharma Services Limited, formerly known as Healthcare at Home, is a leading pharmaceutical supplier and home healthcare provider based in Burton on Trent, UK. Established in 1992 by founder and former chairman Charles Walsh, the company has grown to employ around 1,700 people and serve over 230,000 patients annually across the UK.The company's core services include pharmaceutical supply and distribution, home healthcare services, and specialty pharmacy services.
Sciensus supplies a wide range of pharmaceuticals to patients, healthcare providers, and pharmaceutical companies, working with every NHS trust in the UK to ensure patients have access to the medications they need. The company also specializes in providing in-home care for patients with long-term conditions, rare diseases, and cancer, with a team of healthcare professionals delivering treatments and therapies directly to patients' homes, improving access and convenience.
Additionally, Sciensus offers bespoke services to connect pharmaceutical companies, insurers, and healthcare professionals with patients who require rare, orphan, or hard-to-access medications, including global distribution and patient support programs.However, in 2023, Sciensus faced regulatory issues, including a partial suspension of its license by the MHRA following an incident involving unlicensed chemotherapy treatments. The company was also given a warning by the Parliamentary and Health Service Ombudsman regarding its complaints handling process. Despite these challenges, Sciensus remains a significant player in the UK's healthcare landscape, providing essential services to thousands of patients.
Sciensus Pharma Services Limited in the News:-
Sciensus Pharma Services Limited - Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI’s, and Recent Trends is a comprehensive and easily accessible overview of Sciensus Pharma Services Limited 's business operations. It provides a detailed analysis of the company's strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Sciensus Pharma Services Limited including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Sciensus Pharma Services Limited's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. By integrating these strategic analyses, the report offers a comprehensive understanding of Sciensus Pharma Services Limited's overall strategic standing and supports informed decision-making and strategic planning.
Finally, the report includes recent news and deal activities undertaken by Sciensus Pharma Services Limited enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Sciensus Pharma Services Limited, formerly known as Healthcare at Home, is a leading pharmaceutical supplier and home healthcare provider based in Burton on Trent, UK. Established in 1992 by founder and former chairman Charles Walsh, the company has grown to employ around 1,700 people and serve over 230,000 patients annually across the UK.The company's core services include pharmaceutical supply and distribution, home healthcare services, and specialty pharmacy services.
Sciensus supplies a wide range of pharmaceuticals to patients, healthcare providers, and pharmaceutical companies, working with every NHS trust in the UK to ensure patients have access to the medications they need. The company also specializes in providing in-home care for patients with long-term conditions, rare diseases, and cancer, with a team of healthcare professionals delivering treatments and therapies directly to patients' homes, improving access and convenience.
Additionally, Sciensus offers bespoke services to connect pharmaceutical companies, insurers, and healthcare professionals with patients who require rare, orphan, or hard-to-access medications, including global distribution and patient support programs.However, in 2023, Sciensus faced regulatory issues, including a partial suspension of its license by the MHRA following an incident involving unlicensed chemotherapy treatments. The company was also given a warning by the Parliamentary and Health Service Ombudsman regarding its complaints handling process. Despite these challenges, Sciensus remains a significant player in the UK's healthcare landscape, providing essential services to thousands of patients.
Sciensus Pharma Services Limited in the News:-
- 13-May-2025 - Sciensus achieves 95% patient satisfaction and record NPS
- 23-Apr-2025 - Sciensus achieves ISO 14001 accreditation
- 23-Apr-2025 - Sciensus announces appointment of Kerry Utton as it continues to strengthen its pharma capabilities
- 02-Apr-2025 - Sciensus Easter 2025 bank holiday opening hours
- 28-Feb-2025 - Sciensus’ new depot allows for increased capacity and improved environmental and social impact
- Tactical Analysis:- Various strategic frameworks to gain insights into a Sciensus Pharma Services Limited's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the Sciensus Pharma Services Limited's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Company Fundamentals:- These fundamentals offer valuable insights into the Sciensus Pharma Services Limited's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the Sciensus Pharma Services Limited's main competitors, providing insights into the competitive landscape it operates in.
- Comprehensive Understanding of the Sciensus Pharma Services Limited's internal and external factors through SWOT analysis and Corporate Strategy.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
- Sciensus Pharma Services Limited PESTLE Analysis
- Sciensus Pharma Services Limited Value Chain Analysis
- Sciensus Pharma Services Limited Porter's Five Forces Analysis
- Sciensus Pharma Services Limited VRIO Analysis
- Sciensus Pharma Services Limited BCG Analysis
- Sciensus Pharma Services Limited Segmentation, Targeting and Positioning (STP) Analysis
- Sciensus Pharma Services Limited Ansoff Matrix Analysis
Table of Contents
70 Pages
- Table of Contents
- Tables
- Charts
- Sciensus Pharma Services Limited - Key Company Facts
- Sciensus Pharma Services Limited - Company Description
- Sciensus Pharma Services Limited - Top Executives
- Sciensus Pharma Services Limited - Head Office & Locations
- Head Office - Country
- Sciensus Pharma Services Limited - Products and Services
- Services
- Sciensus Pharma Services Limited - Corporate Strategy
- Sciensus Pharma Services Limited - Business Description
- Homecare Services
- Clinical Services
- Supply Chain Solutions
- Consulting and Support Services
- Sciensus Pharma Services Limited - ESG Spotlight
- Environment
- Social
- Corporate Governance
- Sciensus Pharma Services Limited - SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Competing Players
- Snapshot of Competing Players
- Health Catalyst Inc.
- Key Company Facts
- Company Description
- Key Financials
- Share Price Trend - Jan-2024 to Jun-2025 (Average Share Closing Price)
- Key Financial Ratio Analysis
- NextGen Healthcare Inc.
- Key Company Facts
- Company Description
- Veeva Systems Inc
- Key Company Facts
- Company Description
- Key Financials
- Share Price Trend - May-2024 to Jun-2025 (Average Share Closing Price)
- Key Financial Ratio Analysis
- athenahealth Inc
- Key Company Facts
- Company Description
- Phreesia Inc
- Key Company Facts
- Company Description
- Key Financials
- Share Price Trend - Jan-2024 to Jun-2025 (Average Share Closing Price)
- Key Financial Ratio Analysis
- Sciensus Pharma Services Limited - In the News
- 13-May-2025- Sciensus achieves 95% patient satisfaction and record NPS
- 23-Apr-2025- Sciensus achieves ISO 14001 accreditation
- 23-Apr-2025- Sciensus announces appointment of Kerry Utton as it continues to strengthen its pharma capabilities 02-Apr-2025- Sciensus Easter 2025 bank holiday opening hours
- 28-Feb-2025- Sciensus' new depot allows for increased capacity and improved environmental and social impact
- 20-Jun-2024- Personalised Vaccines and Cancer Treatment
- 10-May-2024- Sciensus hosts a panel at the World Orphan Drug Congress 2024 08-May-2024- Sciensus partners with Observia to improve medication adherence through behavioural insights
- 29-Feb-2024- Sciensus partners with ITN and Genetic Alliance UK for Rare Disease Day
- 28-Feb-2024- Sciensus to integrate pathology test results into iQemo
- Appendix
- Definitions
- SWOT Analysis
- PESTLE Analysis
- Value Chain Analysis
- ESG Spotlight
- Research Methodology
- Disclaimer
- Contact Us
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.